Healthcare Mergers, Acquisitions & Ventures Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions & Ventures Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
AnaSpec, Inc.
Eurogentec Announces Agreement to Acquire AnaSpec, Inc.
November 7th, 2009
Eurogentec S.A. ("Eurogentec") announces a final agreement for the acquisition of AnaSpec, Inc. ("AnaSpec" or the "Company"), a privately-held proteomics company based in Fremont, California. Founded in 1993, AnaSpec is a leading provider of integrated proteomics solutions for life science research and diagnostics with expertise in peptides synthesis, labeled peptides and antibodies, fluorescent dyes and enzyme activity assays. AnaSpec has developed one of the world's largest collections of catalog and dye-labeled peptides in the fields of Alzheimer Disease, Multiple Sclerosis and enzyme inhibitor screening. Leveraging its expertise in peptide, antibodies and fluorescent dyes, AnaSpec has...
Source: Healthcare Mergers, Acquisitions & Ventures Week (2009-11-07)
|
